Skip to main content Help with accessibility Skip to main navigation

TOLVAPTAN tablets (Samsca®) for the treatment of hyponatraemia secondary to the syndrome of inappropriate antidiuretic hormone secretion (SIADH)

CCG Approval Status:

Ha
Kn
Li
SF
SS
SH
Wa
WL
Wi
Date Added: 20 - Aug - 2020
Body System:
Red
TOLVAPTAN tablets (Samsca®) for the treatment of hyponatraemia secondary to the syndrome of inappropriate antidiuretic hormone secretion (SIADH)

The Pan Mersey Area Prescribing Committee recommends the prescribing of TOLVAPTAN tablets (Samsca®), by specialists only, for the treatment of hyponatraemia secondary to SIADH due to any cause.